Researchers explore the risks of cardiovascular and cerebrovascular events following vaccination against the COVID-19.
AffyImmune’s layoffs; Henlius makes a biosimilar deal with Dr. Reddy’s
Plus, news about X4 Pharmaceuticals, Viracta Therapeutics, Crown Laboratories, Qlaris and Hitachi. AffyImmune’s layoffs: The CAR-T biotech went through a round of layoffs and restructuring